Rudd R M, Gellert A R, Boldy D A, Studdy P R, Pearson M C, Geddes D M, Sinha G
Thorax. 1982 Jun;37(6):462-5. doi: 10.1136/thx.37.6.462.
The cell type of bronchial carcinoma predicted from the results of bronchial biopsy at fibreoptic or rigid bronchoscopy or of percutaneous aspiration lung biopsy was compared with the type determined by histological examination of specimens obtained by thoracotomy, biopsy of an extrapulmonary metastasis, or necropsy in 180 cases. The rates of agreement with the final diagnosis were 95.7% for bronchial biopsy through the fibreoptic bronchoscope and 86.5% through the rigid bronchoscope. For percutaneous biopsy, which was usually carried out on tumours inaccessible to the bronchoscope, the rate of agreement was 61%, significantly lower than by the other methods (p less than 0.001). The diagnosis of oat-cell carcinoma by any technique was very reliable. Bronchial biopsy was more reliable than was percutaneous biopsy in diagnosing squamous-cell carcinoma. With any technique the commonest error was the incorrect diagnosis of squamous-cell carcinoma or adenocarcinoma as large-cell undifferentiated carcinoma.
将通过纤维支气管镜或硬支气管镜进行支气管活检的结果,或经皮肺穿刺活检结果所预测的支气管癌细胞类型,与通过开胸手术获取的标本、肺外转移灶活检或尸检所确定的180例病例的组织学类型进行比较。纤维支气管镜下支气管活检与最终诊断的符合率为95.7%,硬支气管镜下为86.5%。对于通常在支气管镜无法到达的肿瘤上进行的经皮活检,符合率为61%,显著低于其他方法(p<0.001)。用任何技术诊断燕麦细胞癌都非常可靠。在诊断鳞状细胞癌方面,支气管活检比经皮活检更可靠。无论采用何种技术,最常见的错误是将鳞状细胞癌或腺癌误诊为大细胞未分化癌。